Quick Answer
Organon & Co. reported Total Assets of $12.87 billion for fiscal year 2025.
Organon & Co. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $12.87B | -1.8% |
| 2024 | $13.10B | +8.6% |
| 2023 | $12.06B | +10.1% |
| 2022 | $10.96B | +2.6% |
| 2021 | $10.68B | +5.7% |
| 2020 | $10.11B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.55B | +6.3% | +0.4% |
| June 30, 2025 | $13.50B | +11.1% | +2.6% |
| March 31, 2025 | $13.16B | +10.6% | +0.4% |
| December 31, 2024 | $13.10B | +8.6% | +2.7% |
| September 30, 2024 | $12.75B | +15.8% | +4.9% |
| June 30, 2024 | $12.15B | +10.7% | +2.2% |
| March 31, 2024 | $11.89B | +10.5% | -1.4% |
| December 31, 2023 | $12.06B | +10.1% | +9.5% |
- Organon & Co. showed a decrease of -1.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Organon & Co.’s total assets has grown by 27.3% (from $10.11 billion to $12.87 billion).
- The most recent figure is from Organon & Co.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: